25% Tilmicosin Oral Ngwọta maka ọkụkọ
.png)
.png)
.png)
.png)
Ihe mejupụtara
100ml nwere 25g tilmicosin.
Pharmacological omume
Pharmacodynamics Teicoplanin bụ ọgwụ nje macrolide semisynthetic raara nye anụmanụ.Maka mycoplasma, mmetụta antibacterial yiri nke tylosin, na nje bacteria na-emetụ gram-positive bụ Staphylococcus aureus (gụnyere staphylococcus aureus na-eguzogide penicillin), pneumococcus, streptococcus, streptococcus, Bacillus anthracis, Erysipelothrix rhusiopathiacytenusunusunus monogens, Porticiene, Listerienus. emphysematosus.Nje bacteria gram-adịghị mma gụnyere Haemophilus, meningococcus na Pasteurella.Ọ na-arụ ọrụ karịa tylosin megide Actinobacillus pleuropneumoniae, Pasteurella na Mycoplasma bovis.Pasent iri itoolu na ise nke ụdị Pasteurella hemolytica nwere ike ịnweta ngwaahịa a.
Pharmacokinetics
A na-etinye ihe ngwọta Tilmicosin ngwa ngwa mgbe nchịkwa ọnụ gasịrị ma mara ya site na ntinye anụ ahụ siri ike na oke nkesa (karịa 2 L / kg).Ntinye uche na ngụgụ dị elu, nkwụsị nke ọkara ndụ nwere ike iru 1 ruo ụbọchị 2, a na-echekwa ntinye uche plasma dị irè ruo ogologo oge.
Mmekọrịta ọgwụ
(1) Tilmicosin nwere otu ebumnuche dị ka macrolides ndị ọzọ na lincosamines na ekwesịghị iji ya n'otu oge.
(2) Nchikota na β-lactams gosipụtara mmegide.
Oge mwepụ
27 ụbọchị tupu igbummadu.
Ọ bụghị maka iji na mmiri ara ehi ehi nke ozuzu, ma ọ bụ ọ bụla anụ ụlọ n'oge mbụ 45 ụbọchị ime (ma ọ bụ mbụ 45 ụbọchị mgbe wepụ ehi)
Omume na ojiji
Ọgwụ nje macrolide.A na-eji ya maka ọgwụgwọ ọrịa iku ume ọkụkọ nke Pasteurella na Mycoplasma kpatara.
Usoro onunu ogwu na nchịkwa
Ihe ọṅụṅụ agwakọtara: 0,3 ml kwa 1 L mmiri maka ọkụkọ.Maka ụbọchị 3.
Mmeghachi omume ọjọọ
Mmetụta na-egbu egbu nke ngwaahịa a na anụmanụ bụ usoro akwara obi, nke nwere ike ime ka tachycardia na ike ọgwụgwụ.
Mkpachapụ anya
Tilmicosin ngwọta ọnụ bụ contraindicated n'ịtọ ọkụkọ n'oge ịtọgbọrọ chakoo.
Oge mwepụ
Chickens maka ụbọchị iri na abụọ.
Nchekwa
Na-echekwa na ọnọdụ mkpuchi, na-echebe site na ìhè.
Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.
Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.
Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.
